All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
A cure for coronavirus already exists
Last reviewed: 02.07.2025
Today, everyone knows about such a pathology as COVID-19 - both children and adults. We are talking about an infectious disease caused by the SARS-CoV-2 coronavirus, identified in 2019 and becoming a global problem on the planet. After the pandemic was declared, the main task of scientists was to create a vaccine that would protect people from infection, as well as to develop the most effective treatment for the disease. Vaccination was soon launched, but nothing was known about new effective drugs until now. COVID-19 was treated mainly with drugs such as Tamiflu, Dexamethasone (a corticosteroid), Bamlanivimab, Casirivimab and Imdevimab (monoclonal antibody-based drugs), Avigan (Favilavir), Ivermectin, etc. These drugs demonstrate some effectiveness, but they themselves have a lot of side effects, sometimes quite serious.
Just recently, Australian scientists gave the world new hope by announcing the creation of a long-awaited drug. The new drug not only alleviates the symptoms of coronavirus infection, but reduces the presence of the virus in the body by 99.9%. Specialists have already successfully tested the drug on rodents in a laboratory setting.
The new drug was developed in close collaboration with the City of Hope Cancer and Diabetes Therapy Research Center and the Griffith University Health Institute. Scientists explain that the drug actually cures coronavirus infection, and not just speeds up recovery. The basic composition of the drug is due to the use of siRNA (small interfering RNA) technology, which can directly affect the viral genome and cause its death. As a result, the pathogen completely loses the ability to reproduce.
Test trials on rodents have shown that treatment using miRNA technology dramatically reduces the level of the viral pathogen in the body by almost 100%. In addition, the therapeutic drug base can be stored for up to 12 months at a temperature of +4°C, and up to 4 weeks at room temperature.
Professor Macmillan, who took part in the creation of the medicine, draws attention to the fact that the use of the new technology led to a complete recovery of the experimental rodents. Moreover, after the treatment, it was not possible to detect the virus in their lungs.
The developed product can be called universal: it works on the entire range of beta-coronaviruses, including the SARS-CoV-1 virus, SARS-CoV-2, as well as other variations that may appear in the future.
The researchers have every reason to believe that the drug they created could soon be used in therapeutic regimens for patients with coronavirus infection. At the moment, scientists are starting to conduct trials involving volunteers.
The results of the work are published on the Griffith University website